Proinflammatory and osteoclastogenic effects of beta-tricalciumphosphate and hydroxyapatite particles on human mononuclear cells in vitro

Biomaterials

Volumn 30, Issue 29, 2009, Pages 5312-5318

  Lange, Tobias ^a   Schilling, Arndt F ^a,b   Peters, Fabian ^c   Haag, Friedrich ^a   Morlock, Michael M ^b   Rueger, Johannes M ^a   Amling, Michael ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b HAMBURG UNIVERSITY OF TECHNOLOGY   (Germany)

^c Curasan AG   (Germany)

Author keywords

Beta TCP; Dendritic cells; Human PBMC; Hydroxyapatite; Inflammation; Osteoclastogenesis

Indexed keywords

BETA-TCP; DENDRITIC CELLS; HUMAN PBMC; INFLAMMATION; OSTEOCLASTOGENESIS;

APATITE; BIOLOGICAL MATERIALS; BIOMATERIALS; BONE; CELL MEMBRANES; DEBRIS; DENDRIMERS; DRUG PRODUCTS; GRANULAR MATERIALS; HYDROXYAPATITE; HYDROXYLATION; PATHOLOGY; SURFACE TREATMENT;

TRANSMISSION CONTROL PROTOCOL;

CALCIUM PHOSPHATE; COLONY STIMULATING FACTOR 1; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYAPATITE; INTERLEUKIN 1BETA; INTERLEUKIN 8; OSTEOCLAST DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE PROSTHESIS; CELL DIFFERENTIATION; CERAMICS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; MONONUCLEAR CELL; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN INDUCTION;

CALCIUM PHOSPHATES; CELLS, CULTURED; CYTOKINES; DURAPATITE; HUMANS; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; OSTEOCLASTS; PARTICLE SIZE;

EID: 68549104032     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.06.023     Document Type: Article

References (45)

1. de Groot K. Bioceramics consisting of calcium phosphate salts. Biomaterials 1 (1980) 47-50
2. Dorozhkin S.V., and Epple M. Biological and medical significance of calcium phosphates. Angew Chem Int Ed Engl 41 (2002) 3130-3146
3. Knop C., Sitte I., Canto F., Reinhold M., and Blauth M. Successful posterior interlaminar fusion at the thoracic spine by sole use of beta-tricalcium phosphate. Arch Orthop Trauma Surg 126 (2006) 204-210
4. Jaffe W.L., and Scott D.F. Total hip arthroplasty with hydroxyapatite-coated prostheses. J Bone Joint Surg Am 78 (1996) 1918-1934
5. Huracek J., and Spirig P. The effect of hydroxyapatite coating on the fixation of hip prostheses. A comparison of clinical and radiographic results of hip replacement in a matched-pair study. Arch Orthop Trauma Surg 113 (1994) 72-77
6. D'Antonio J.A., Capello W.N., Manley M.T., and Feinberg J. Hydroxyapatite coated implants: total hip arthroplasty in the young patient and patients with avascular necrosis. Clin Orthop Relat Res 344 (1997) 124-138
7. Morscher J., Hefti A., and Aebi U. Severe osteolysis after third-body wear due to hydroxyapatite particles from acetabular cup coating. J Bone Joint Surg Br 80 (1998) 267-272
8. Bloebaum R.D., Zou L., Bachus K.N., Shea K.G., Hofmann A.A., and Dunn H.K. Analysis of particles in acetabular components from patients with osteolysis. Clin Orthop Relat Res 338 (1997) 109-118
9. de Groot K. Effect of porosity and physicochemical properties on the stability, resorption and strength of calcium phosphate ceramics. Ann N Y Acad Sci 523 (1988) 227-233
10. Lu J., Descamps M., Dejou J., Koubi G., Hardouin P., Lemaitre J., et al. The biodegradation mechanism of calcium phosphate biomaterials in bone. J Biomed Mater Res 63 (2002) 408-412
11. Anderson J.M. Inflammatory response to implants. Trans Am Soc Artif Intern Organs 34 (1988) 101-107
12. Shimizu S. Subcutaneous tissue responses in rats to injection of fine particles of synthetic hydroxyapatite ceramic. Biomed Res 9 (1988) 95-111
13. Goodman S.B., Huie P., Song Y., Lee K., Doshi A., Rushdieh B., et al. Loosening and osteolysis of cemented joint arthroplasties: a biologic spectrum. Clin Orthop Relat Res 337 (1997) 149-163
14. Goodman S.B., Knoblich G., O'Connor M., Song Y., Huie P., and Sibley R. Heterogeneity in cellular and cytokine profiles from multiple samples of tissue surrounding revised hip prostheses. J Biomed Mater Res 31 (1996) 421-428
15. Goodman S.B., Lind M., Song Y., and Smith R.L. In vitro, in vivo, and tissue retrieval studies on particulate debris. Clin Orthop Relat Res 352 (1998) 25-34
16. Jiranek W.A., Machado M., Jasty M., Jevsevar D., Wolfe H.J., Goldring S.R., et al. Production of cytokines around loosened cemented acetabular components. J Bone Joint Surg 75 (1993) 863-879
17. Al-Saffar N., and Revell P.A. Interleukin-1 production by activated macrophages surrounding loosened orthopaedic implants: a potential role in osteolysis. Br J Rheumatol 33 (1994) 309-316
18. Kaji K., Katogi R., Azuma Y., Naito A., Inoue J.I., and Kudo A. Tumor necrosis factor alpha-induced osteoclastogenesis requires tumor necrosis factor receptor-associated factor 6. J Bone Miner Res 16 (2001) 1593-1599
19. Grandjean-Laquerriere A., Laquerriere P., Guenounou M., Laurent-Maquin D., and Phillips T.M. Importance of the surface area ratio on cytokines production by human monocytes in vitro induced by various hydroxyapatite particles. Biomaterials 26 (2005) 2361-2369
20. Curran J.M., Gallagher J.A., and Hunt J.A. The inflammatory potential of biphasic calcium phosphate granules in osteoblast/macrophage co-culture. Biomaterials 26 (2005) 5313-5320
21. Shanbhag A.S., Jacobs J.J., Black J., Galante J.O., and Glant T.T. Human monocyte response to particulate biomaterials generated in vivo and vitro. J Orthop Res 13 (1995) 792-801
22. Matthews J.B., Besong A.A., Green T.R., Stone M.H., Wroblewski B.M., Fisher J., et al. Evaluation of the response of primary human peripheral blood mononuclear phagocytes to challenge with in vitro generated clinically relevant UHMWPE particles of known size and dose. J Biomed Mater Res 52 (2000) 296-307
23. Gonzalez O., Smith R.L., and Goodman S.B. Effect of size, concentration, surface area, and volume of polymethylmethacrylate particles on human macrophages in vitro. J Biomed Mater Res 30 (1996) 463-473
24. Kaufman A.M., Alabre C.I., Rubash H.E., and Shanbhag A.S. Human macrophage response to UHMWPE, TiAlV, CoCr and alumina particles: analysis of multiple cytokines using protein assays. J Biomed Mater Res A 84 (2008) 464-474
25. Williams D.F. On the mechanisms of biocompatibility. Biomaterials 29 (2008) 2941-2953
26. Shanbhag A.S., Yang J., Lilien J., and Black J. Decreased neutrophil respiratory burst on exposure to cobalt-chrome alloy and polystyrene in-vitro. J Biomed Mater Res 26 (1992) 185-195
27. Yang J., Shanbhag A.S., Lilien J., and Black J. Human neutrophil response to short-term exposure to F-75 cobalt-based alloy. J Biomed Mater Res 26 (1992) 1217-1230
28. Schilling A.F., Linhart W., Filke S., Gebauer M., Schinke T., Rueger J.M., et al. Resorbability of bone substitute biomaterials by human osteoclasts. Biomaterials 25 (2004) 3963-3972
29. Smith C.I., Hammarström L., Bird A.G., Kunori T., Gustafsson B., and Holme T. Lipopolysaccharide and lipid A-induced human blood lymphocyte activation as detected by a protein A plaque assay. Eur J Immunol 9 (1979) 619-625
30. Sato M., Sano H., Iwaki D., Kudo K., Konishi M., Takahashi H., et al. Direct binding of toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation and TNF-alpha secretion are down-regulated by lung collectin surfactant protein A. J Immunol 171 (2003) 417-425
31. van der Meulen J., and Koerten H.K. Inflammatory response and degradation of three types of calcium phosphate ceramic in a non-osseus environment. J Biomed Mater Res 28 (1994) 1455-1463
32. Harada Y., Wang J.T., Doppalapudi V.A., Willis A.A., Jasty M., Harris W.H., et al. Differential effects of different forms of hydroxyapatite and hydroxyapatite/tricalcium phosphate particulates on human monocyte/macrophages in vitro. J Biomed Mater Res 31 (1996) 19-26
33. Nadra I., Boccaccini A.R., Philippidis P., Whelan L.C., McCarthy G.M., Haskard D.O., et al. Effect of particle size on hydroxyapatite crystal-induced tumor necrosis factor alpha secretion by macrophages. Atherosclerosis 196 (2008) 98-105
34. Campbell P., Ma S., Yeom B., McKellop H.A., Schmalzried T.P., and Amstutz H.C. Isolation of predominantly submicron-sized UHMWPE wear particles from periprosthetic tissues. J Biomed Mater Res 29 (1995) 127-131
35. Shanbhag A.S., Jacobs J.J., Glant T.T., Gilbert J.L., Black J., and Galante J.O. Composition and morphology of wear debris in failed uncemented total hip replacement. J Bone Joint Surg Br 76 (1994) 60-67
36. Shanbhag A.S., Jacobs J.J., Black J., Galante J.O., and Glant T.T. Macrophage/particle interactions: effect of size, composition and surface area. J Biomed Mater Res 28 (1994) 81-90
37. Bi Y., Seabold J.M., Kaar S.C., Ragab A.A., Goldberg V.M., Anderson J.M., et al. Adherent endotoxin on orthopaedic wear particles stimulates cytokine production and osteoclast differentiation. J Bone Miner Res 16 (2001) 2082-2091
38. Akisue T., Bauer T.W., Farver C.F., and Mochida Y. The effect of particle wear debris on NFκB activation and pro-inflammatory cytokine release in differentiated THP-1 cells. J Biomed Mater Res 59 (2002) 507-515
39. Wu L., and Dakic A. Development of dendritic cell system. Cell Mol Immunol 1 (2004) 112-118
40. Lebre M.C., and Tak P.P. Dendritic cell subsets: their roles in rheumatoid arthritis. Acta Rheumatol Port 33 (2008) 35-45
41. Miyamoto T., Ohneda O., Arai F., Iwamoto K., Okada S., Takagi K., et al. Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood 98 (2001) 2544-2554
42. Rivollier A., Mazzorana M., Tebib J., Piperno M., Aitsiselmi T., Rabourdin-Combe C., et al. Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment. Blood 104 (2004) 4029-4037
43. Schilling A.F., Filke S., Lange T., Gebauer M., Brink S., Baranowsky A., et al. Gap junctional communication in human osteoclasts in vitro and in vivo. J Cell Mol Med 12 (2008) 2497-2504
44. Childs L.M., Paschalis E.P., Xing L., Dougall W.C., Anderson D., Boskey A.L., et al. In vivo RANK signaling blockade using the receptor activator of NF-κB: Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis. J Bone Miner Res 17 (2002) 192-199
45. Zerbo I.R., Bronckers A.L., de Lange G., and Burger E.H. Localisation of osteogenic and osteoclastic cells in porous b-tricalcium phosphate particles used for human maxillary sinus floor elevation. Biomaterials 26 (2005) 1445-1451